Correlation Between FiscalNote Holdings and Tarsus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both FiscalNote Holdings and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FiscalNote Holdings and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between FiscalNote Holdings and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on FiscalNote Holdings and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FiscalNote Holdings with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of FiscalNote Holdings and Tarsus Pharmaceuticals.
Diversification Opportunities for FiscalNote Holdings and Tarsus Pharmaceuticals
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between FiscalNote and Tarsus is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding FiscalNote Holdings and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and FiscalNote Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FiscalNote Holdings are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of FiscalNote Holdings i.e., FiscalNote Holdings and Tarsus Pharmaceuticals go up and down completely randomly.
Pair Corralation between FiscalNote Holdings and Tarsus Pharmaceuticals
Given the investment horizon of 90 days FiscalNote Holdings is expected to under-perform the Tarsus Pharmaceuticals. In addition to that, FiscalNote Holdings is 2.24 times more volatile than Tarsus Pharmaceuticals. It trades about -0.02 of its total potential returns per unit of risk. Tarsus Pharmaceuticals is currently generating about -0.01 per unit of volatility. If you would invest 5,470 in Tarsus Pharmaceuticals on December 29, 2024 and sell it today you would lose (296.00) from holding Tarsus Pharmaceuticals or give up 5.41% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
FiscalNote Holdings vs. Tarsus Pharmaceuticals
Performance |
Timeline |
FiscalNote Holdings |
Tarsus Pharmaceuticals |
FiscalNote Holdings and Tarsus Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with FiscalNote Holdings and Tarsus Pharmaceuticals
The main advantage of trading using opposite FiscalNote Holdings and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FiscalNote Holdings position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.FiscalNote Holdings vs. Innodata | FiscalNote Holdings vs. International Business Machines | FiscalNote Holdings vs. Aurora Innovation | FiscalNote Holdings vs. BigBearai Holdings |
Tarsus Pharmaceuticals vs. Emergent Biosolutions | Tarsus Pharmaceuticals vs. Bausch Health Companies | Tarsus Pharmaceuticals vs. Neurocrine Biosciences | Tarsus Pharmaceuticals vs. Teva Pharma Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |